Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial

NCT07027020 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT07027020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07027020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial
Lead sponsor
Central Hospital, Nancy, France
Phase
Phase 3
Overall status
Recruiting
Start date
January 15, 2026
Completion date
June 30, 2028
Enrollment
60 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

spina bifida